FindTrial
Sign In

Bringing Neuroimaging and Genetics to the Clinic: A case for Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder

Bringing Neuroimaging and Genetics to the Clinic: A case for Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder - Clinical Neuroimaging and Genetics of ADHD and ASD

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44585
Enrollment
1125
Registered
2016-05-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention-Deficit/Hyperactivity Disorder

Interventions

Attention-Deficit/Hyperactivity Disorder
Autism Spectrum Disorder
Genetics
Magnetic Resonance Imaging

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: - Referral to Karakter Child and Adolescent Psychiatry, to be evaluated for ADHD or ASD. - Aged 8 years * 18 years at initial inclusion - Signed informed consent by parents or legal representative - Ability to speak and comprehend Dutch

Exclusion criteria

Exclusion criteria: - Contra-indications for MRI assessment, such as the presence of metal objects in or around the body (pacemaker, dental braces)

Design outcomes

Primary

MeasureTime frame
Classifiers, and associated multimodal biomarker profiles, for application of neuroimaging and genetics in the diagnostic process, prognostics and treatment selection in ADHD and ASD.—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)